Panacur Equine 187.5 mg/g Oral Paste
Panacur Equine 187.5 mg/g Oral Paste
Authorised
- Fenbendazole
Product identification
Medicine name:
Panacur Equine 187.5 mg/g Oral Paste
Active substance:
- Fenbendazole
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Fenbendazole187.50/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Oral paste
Withdrawal period by route of administration:
-
Oral use
-
Horse
-
Meat and offal14day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Available in:
-
Ireland
Package description:
- White opaque metered polyethylene syringe, push-fit cap and adjusting ring containing 24 g Panacur Paste. The bodyof the syringe is made of high density polyethylene (HDPE). The push-fit cap is composed of Low Densitypolyethylene as is the plunger rod and plunger head. The metering device is made of HDPE. 10 syringes per carton
- White opaque metered polyethylene syringe, push-fit cap and adjusting ring containing 24 g Panacur Paste. The bodyof the syringe is made of high density polyethylene (HDPE). The push-fit cap is composed of Low Densitypolyethylene as is the plunger rod and plunger head. The metering device is made of HDPE. 20 syringes per carton
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet Productions S.A.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/118/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 25/09/2024